Liselotte Hyveled
Member of the Board
Research & Development Committee
Novo Nordisk
Belarus
Biography
Ms Hyveled joined Novo Nordisk in 1992 and is currently working as a Project Vice President for the faster-acting insulin aspart and liver-preferential mealtime insulin in Global Development. Ms Hyveled holds a Master of Science from Copenhagen University, Denmark, from 1992 and a Master of Medical Business Strategies from Copenhagen Business School, Denmark, from 2011. Liselotte Hyveled has been an employee-elected member of the Board of Directors since March 2014. Her term as a board member expires in March 2018. Ms Hyveled became a member of the Research & Development Committee at Novo Nordisk A/S in March 2017.
Research Interest
Healthcare, Research and Development, Sceience Technology, Medical Business Strategies etc.